ferricarboxymaltaatti

Ferricarboxymaltose is an intravenous iron replacement product used to treat iron deficiency anemia. It is a complex of ferric iron and a carbohydrate molecule called carboxymaltose. This formulation allows for the safe and effective delivery of a large dose of iron into the bloodstream, which is then absorbed by the body and used to produce red blood cells.

The administration of ferricarboxymaltose is typically done in a healthcare setting by a trained medical professional due to the potential for infusion-related reactions. The dosage and duration of treatment are determined by the individual patient's needs and the severity of their iron deficiency. It is often used when oral iron therapy is ineffective or not tolerated, or when rapid iron repletion is required.

Common side effects can include nausea, vomiting, diarrhea, constipation, headache, and dizziness. More serious, though less common, side effects can include allergic reactions, low blood pressure, and iron overload. Patients with certain medical conditions, such as severe asthma or other hypersensitivity disorders, may require particular caution. Ferricarboxymaltose is not a substitute for treating the underlying cause of iron deficiency anemia.